[Pharmacokinetic properties and indications for modern vasodilators. 1. Pharmacodynamic properties of vasodilators].
Langnickel
R
R
Bluth
R
R
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000787:Angina Pectoris / Q000188:drug therapy; D000806:Angiotensin-Converting Enzyme Inhibitors; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D002216:Captopril / Q000627:therapeutic use; D003327:Coronary Disease / Q000188:drug therapy; D003981:Diazoxide / Q000627:therapeutic use; D004361:Drug Tolerance; D004656:Enalapril / Q000627:therapeutic use; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D006973:Hypertension / Q000188:drug therapy; D008914:Minoxidil / Q000627:therapeutic use; D009130:Muscle, Smooth / Q000187:drug effects; D005996:Nitroglycerin / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use*
D000317:Adrenergic alpha-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D014665:Vasodilator Agents; D006830:Hydralazine; D008914:Minoxidil; D004656:Enalapril; D002216:Captopril; D005996:Nitroglycerin; D003981:Diazoxide
Pharmakologische Eigenschaften und Indikationen moderner Vasodilatatoren. Teil 1: Pharmakodynamische Eigenschaften der Vasodilatatoren.